These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8412984)

  • 1. Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta.
    Valli M; Rossi A; Forlino A; Tenni R; Cetta G
    Matrix; 1993 Jul; 13(4):275-80. PubMed ID: 8412984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta.
    Cetta G; Rossi A; Tenni R; Valli M; Forlino A; Zanaboni G; Dyne K; Burgio GR
    Connect Tissue Res; 1993; 29(1):41-9. PubMed ID: 8339545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
    Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
    Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta.
    Steinmann B; Rao VH; Vogel A; Bruckner P; Gitzelmann R; Byers PH
    J Biol Chem; 1984 Sep; 259(17):11129-38. PubMed ID: 6469997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix.
    Cabral WA; Mertts MV; Makareeva E; Colige A; Tekin M; Pandya A; Leikin S; Marini JC
    J Biol Chem; 2003 Mar; 278(12):10006-12. PubMed ID: 12538651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro.
    Bateman JF; Golub SB
    Matrix Biol; 1994 Apr; 14(3):251-62. PubMed ID: 7921542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.
    Mundlos S; Chan D; Weng YM; Sillence DO; Cole WG; Bateman JF
    J Biol Chem; 1996 Aug; 271(35):21068-74. PubMed ID: 8702873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.
    Barnes AM; Ashok A; Makareeva EN; Brusel M; Cabral WA; Weis M; Moali C; Bettler E; Eyre DR; Cassella JP; Leikin S; Hulmes DJS; Kessler E; Marini JC
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2210-2223. PubMed ID: 31055083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta.
    Cole WG
    Clin Orthop Relat Res; 1997 Oct; (343):235-48. PubMed ID: 9345229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta.
    Wenstrup RJ; Willing MC; Starman BJ; Byers PH
    Am J Hum Genet; 1990 May; 46(5):975-82. PubMed ID: 2339695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered helical structure of a homotrimer of alpha 1(I)chains synthesized by fibroblasts from a variant of osteogenesis imperfecta.
    Deak SB; van der Rest M; Prockop DJ
    Coll Relat Res; 1985 Sep; 5(4):305-13. PubMed ID: 4053561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta.
    Mirigian LS; Makareeva E; Mertz EL; Omari S; Roberts-Pilgrim AM; Oestreich AK; Phillips CL; Leikin S
    J Bone Miner Res; 2016 Aug; 31(8):1608-1616. PubMed ID: 26925839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of type I collagen in osteogenesis imperfecta.
    Edwards MJ; Graham JM
    J Pediatr; 1990 Jul; 117(1 Pt 1):67-72. PubMed ID: 2370612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Consequences of the SERPINH1/HSP47 Mutation in the Dachshund Natural Model of Osteogenesis Imperfecta.
    Lindert U; Weis MA; Rai J; Seeliger F; Hausser I; Leeb T; Eyre D; Rohrbach M; Giunta C
    J Biol Chem; 2015 Jul; 290(29):17679-17689. PubMed ID: 26004778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
    Galicka A; Wołczyński S; Gindzieński A
    Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta.
    Dyne K; Cetta G; Tenni R; Rossi A; Finardi E; Brunelli PC; Castellani AA
    Ital J Biochem; 1987; 36(4):256-66. PubMed ID: 3429209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
    Barsh GS; Byers PH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of overmodified type I procollagen in a case of osteogenesis imperfecta.
    Tajima S; Takehana M; Azuma N
    J Dermatol; 1994 Apr; 21(4):219-22. PubMed ID: 8056893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility.
    Muriel MP; Bonaventure J; Stanescu R; Maroteaux P; Guénet JL; Stanescu V
    Bone; 1991; 12(4):241-8. PubMed ID: 1793673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.